Patents by Inventor Ian Krane

Ian Krane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090246194
    Abstract: Erythropoietin analog-human IgG fusion protein (EPOa-IgG) fusion protein and methods of making and using the fusion protein.
    Type: Application
    Filed: March 18, 2008
    Publication date: October 1, 2009
    Applicant: GTC Biotherapeutics, Inc.
    Inventors: Harry M. Meade, Ian Krane
  • Publication number: 20070169211
    Abstract: The invention features non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof.
    Type: Application
    Filed: March 9, 2007
    Publication date: July 19, 2007
    Applicant: Merrimack Pharmaceuticals, Inc.
    Inventors: Robert Mulroy, Ian Krane
  • Patent number: 7208576
    Abstract: The invention features non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof.
    Type: Grant
    Filed: July 22, 2003
    Date of Patent: April 24, 2007
    Assignee: Merrimack Pharmaceuticals, Inc.
    Inventors: Robert Mulroy, Ian Krane
  • Patent number: 7101971
    Abstract: Erythropoietin analog-human serum albumin (EPOa-hSA) fusion protein and methods of making and using the fusion protein.
    Type: Grant
    Filed: February 20, 2002
    Date of Patent: September 5, 2006
    Assignee: GTC Biotherapeutics, Inc.
    Inventors: Harry M. Meade, Ian Krane, Michael Young
  • Publication number: 20050181482
    Abstract: Erythropoietin analog-human IgG fusion protein (EPOa-IgG) fusion protein and methods of making and using the fusion protein.
    Type: Application
    Filed: February 3, 2005
    Publication date: August 18, 2005
    Inventors: Harry Meade, Ian Krane
  • Publication number: 20050158832
    Abstract: Erythropoietin analog-human serum albumin (EPOa-hSA) fusion protein and methods of making and using the fusion protein.
    Type: Application
    Filed: December 17, 2004
    Publication date: July 21, 2005
    Inventors: Michael Young, Harry Meade, Ian Krane
  • Publication number: 20040143857
    Abstract: Erythropoietin analog-human serum albumin (EPOa-hSA) fusion protein and methods of making and using the fusion protein.
    Type: Application
    Filed: January 30, 2004
    Publication date: July 22, 2004
    Inventors: Michael Young, Harry Meade, Ian Krane
  • Publication number: 20040098755
    Abstract: The invention features non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof.
    Type: Application
    Filed: July 22, 2003
    Publication date: May 20, 2004
    Inventors: Robert Mulroy, Ian Krane
  • Patent number: 6548653
    Abstract: Erythropoietin analog-human serum albumin (EPOa-hSA) fusion protein and methods of making and using the fusion protein.
    Type: Grant
    Filed: June 15, 1999
    Date of Patent: April 15, 2003
    Assignee: Genzyme Transgenics Corporation
    Inventors: Michael Young, Harry Meade, Ian Krane
  • Publication number: 20020155998
    Abstract: Erythropoietin analog-human serum albumin (EPOa-hSA) fusion protein and methods of making and using the fusion protein.
    Type: Application
    Filed: February 20, 2002
    Publication date: October 24, 2002
    Applicant: Genzyme Transgenics Corporation, a Massachusetts corporation
    Inventors: Michael Young, Harry Meade, Ian Krane